Robert J. Spiegel
CIK 1492256 · Chief Medical Officer · last filed 2026-05-26
Robert J. Spiegel is a Chief Medical Officer who has filed 115 SEC Form 4 insider transactions across 10 companies since 2010. The most recent filing, for GERN, was dated May 26, 2026. Across all open-market trades the lifetime net is −$725.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.46M
10
115
-$725.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GERN | Director | 199,707 | $1.15 | $229.7K | -$719.2K | 67 | 2026-05-26 |
| RNXT | Director | 40,983 | $0.84 | $34.6K | $0 | 5 | 2025-10-02 |
| Bio Green Med Solution, Inc. (CYCCP) Delisted | Director | 39,415 | $5.05 | $199.0K | $0 | 6 | 2023-07-03 |
| Athenex, Inc. (ATNX) Delisted | Director | 4,592 | $0.20 | $933 | $0 | 9 | 2023-04-24 |
| Old Ayala, Inc (AYLA) Delisted | Director | — | $0.50 | — | $0 | 2 | 2022-06-15 |
| PDSB | Director | 48,661 | $1.05 | $51.1K | $0 | 1 | 2019-03-18 |
| EDGE | Director | 38,661 | $49.07 | $1.90M | $33.0K | 5 | 2018-08-15 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | $0 | 5 | 2018-02-13 |
| PTCT | Chief Medical Officer | 3,239 | $75.14 | $243.4K | -$39.7K | 5 | 2016-01-06 |
| CAPS | Director | 10,000 | $0.29 | $3.0K | $0 | 3 | 2012-01-03 |
Recent Filings
115 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | GERN | Grant (A) | — | $0 | EDGAR |
| 2026-04-01 | GERN | Grant (A) | +5,243 | $7.8K | EDGAR |
| 2026-01-05 | GERN | Grant (A) | +5,918 | $7.8K | EDGAR |
| 2025-10-02 | RNXT | Grant (A) | — | $0 | EDGAR |
| 2025-10-01 | GERN | Grant (A) | +5,702 | $7.8K | EDGAR |
| 2025-07-01 | GERN | Grant (A) | +5,540 | $7.8K | EDGAR |
| 2025-05-22 | GERN | Grant (A) | — | $0 | EDGAR |
| 2025-04-02 | GERN | Grant (A) | +2,206 | $7.8K | EDGAR |
| 2025-04-02 | GERN | Grant (A) | +4,378 | $16.2K | EDGAR |
| 2025-04-02 | GERN | Grant (A) | +1,767 | $8.0K | EDGAR |